Neurology
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
To evaluate the efficacy and safety of 500 mg bid and 1500 mg bid levetiracetam as adjunctive therapy for refractory partial seizures in a double-blind, randomized, placebo-controlled, parallel-group, multicenter trial. ⋯ Adjunctive therapy with levetiracetam was effective and well tolerated in controlling partial seizures.